Vilya is a computational biotechnology company that targets disease biology. It designs molecular structures not found in nature, opening doors to therapies for previously untreatable conditions. Their platform eliminates the need for traditional high-throughput screening, accelerating drug discovery and enabling the creation of more effective, drug-like molecules to transform healthcare and cure diseases.
📋 Overview of Vilya
Founding Year
2022
Estimated Funding
Size
$0000
Locations
Primary Industry
📙 About Vilya
💰 Recent Investors of Vilya
Altitude Life Science Ventures, ARCH Venture Partners, Investor
© 2025 Bot Memo. All Rights Reserved.
